<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Rapid detection of methicillin-resistant Staphylococcus aureus
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Rapid detection of methicillin-resistant Staphylococcus aureus
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Rapid detection of methicillin-resistant Staphylococcus aureus
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joshua Freeman, MBChB, FRCPA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Arthur Morris, MD, D(ABMM), FRCPA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Franklin D Lowy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 31, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approaches to rapid detection of methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) include rapid culture methods and molecular techniques. Several studies have examined the role of rapid detection methods as a component of MRSA control strategies.
        </p>
        <p>
         Molecular diagnostic methods can reduce the turnaround time for detection of MRSA colonization and detection of MRSA from positive blood cultures. Rapid MRSA detection tools can also reduce the risk of MRSA surgical site infection, by providing information to guide decisions regarding choice of perioperative antimicrobial prophylaxis and preoperative decolonization.
        </p>
        <p>
         Laboratory tools for rapid detection will be discussed here; the microbiology of MRSA and clinical issues related to MRSA surveillance are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3153.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA): Microbiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4048.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3050861962">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         By definition, all MRSA isolates carry the
         <em>
          mecA
         </em>
         gene or a related variant known as
         <em>
          mecC
         </em>
         . These genes confer resistance to almost all beta-lactam antibiotics, including cephalosporins and carbapenems.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ANATOMIC SAMPLING SITE(S)
         </span>
         <span class="headingEndMark">
          —
         </span>
         For the purposes of MRSA infection control surveillance, the anterior nares are the most common site for MRSA carriage; other important sites include the throat, axilla, groin, and perineum [
         <a href="#rid1">
          1-3
         </a>
         ]. Lower sensitivities have been observed for non-nasal sample sites (eg, throat, axilla), perhaps due to lower colonization rates or higher quantities of competing flora at these sites. Rectal swabs may contain polymerase chain reaction inhibitors and therefore are of limited utility when molecular methods are used [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          LABORATORY TOOLS
         </span>
        </p>
        <p class="headingAnchor" id="H3335764">
         <span class="h2">
          Cefoxitin disk screen test
         </span>
         <span class="headingEndMark">
          —
         </span>
         Apart from using molecular methods to detect the
         <em>
          mecA/mecC
         </em>
         genes directly, the most accurate phenotypic test for the presence of the
         <em>
          mecA/mecC
         </em>
         genes in
         <em>
          S. aureus
         </em>
         is the
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         disk diffusion test. Cefoxitin is used because it is a more potent inducer of
         <em>
          mecA
         </em>
         /
         <em>
          mecC
         </em>
         expression than other agents such as
         <a class="drug drug_general" data-topicid="9724" href="/z/d/drug information/9724.html" rel="external">
          oxacillin
         </a>
         and the test results are relatively easy to interpret. The test involves incubating a lawn of the test isolate on Mueller Hinton agar +2% sodium chloride under standardized conditions with a cefoxitin disk (30 mcg). According to the Clinical and Laboratory Standards Institute (CLSI), a zone of growth inhibition around the cefoxitin disk of ≥22 mm rules out MRSA; a zone size &lt;22 mm indicates that the
         <em>
          mecA
         </em>
         gene is present and the isolate should be reported as MRSA. The test requires overnight incubation [
         <a href="#rid5">
          5
         </a>
         ]. The cefoxitin disk screen test diameter for those using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) is also &lt;22 mm [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32294801">
         <span class="h2">
          Rapid culture
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Chromogenic agar
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rapid culture makes use of chromogenic agar, which contains media substrates that change color in the presence of
         <em>
          S. aureus
         </em>
         ; selectivity for MRSA is achieved by incorporation of antibiotics into the agar. Use of such agar allows identification of MRSA from primary isolation plates within 24 to 48 hours, obviating the need for additional subcultures or biochemical tests [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Chromogenic media are used primarily for detection of MRSA from surveillance specimens (nasal swabs and swabs of the throat, groin, and rectum) [
         <a href="#rid1">
          1
         </a>
         ]. Chromogenic media has also been evaluated for identification of MRSA in blood cultures with high sensitivity and specificity at 18 to 24 hours (97.6 and 100 percent, respectively) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         There are several commercially available chromogenic media [
         <a href="#rid7">
          7
         </a>
         ]. The reported sensitivities of these media vary widely (50 to 100 percent) and depend on the duration of incubation and the "gold standard" comparator [
         <a href="#rid7">
          7,9-16
         </a>
         ]. However, after 24 hours of incubation, the specificities of these media are consistently high (90 to 100 percent). Prolonging the incubation time to 48 hours improves sensitivity but reduces specificity [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Many laboratories use a combination of chromogenic agar (read at 24 hours) and conventional culture methods. This approach allows early detection of many MRSA-colonized patients at 24 hours, with the remainder detected within the conventional 48- to 72-hour timeframe [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32294891">
         <span class="h3">
          Enrichment broth
         </span>
         <span class="headingEndMark">
          —
         </span>
         A novel culture method (BacLite rapid MRSA test) allows a negative result to be reported in five hours, although this assay is not available in the United States [
         <a href="#rid17">
          17
         </a>
         ]. This method uses a selective enrichment broth containing
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         and magnetic microparticle extraction of
         <em>
          S. aureus
         </em>
         followed by detection of adenylate kinase (a nonspecific cell marker). A negative result can be reported after five hours; a positive result can typically be reported the following day. Excellent sensitivity and specificity of this assay for nasal swabs have been reported (94.6 percent and 96.9 percent, respectively), although false-positive reactions with coagulase-negative staphylococci (CoNS) can occur [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Molecular methods
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular assays utilize target DNA sequences that include regions of the SCC
         <em>
          mec
         </em>
         element (which is common in
         <em>
          S. aureus
         </em>
         as well as coagulase-negative staphylococci), together with additional nucleic sequences specific for
         <em>
          S. aureus
         </em>
         . Different assays use different combinations of targets. Notably, not all molecular assays detect the
         <em>
          mecC
         </em>
         variant present in some MRSA [
         <a href="#rid18">
          18,19
         </a>
         ].
        </p>
        <p>
         When used to detect MRSA colonization, the positive and negative predictive values of molecular methods depend upon the prevalence of MRSA in the population. The high sensitivity of these tests results in a high negative predictive value, particularly in low-prevalence settings. Therefore, negative results are useful for exclusion of MRSA in low prevalence settings. Positive results, however, may require confirmation by culture before a definitive diagnosis of MRSA colonization can be made. Conversely, in high-prevalence settings, assays with high specificity may be used to definitively identify MRSA carriers because the positive predictive value will be high.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Commercial assays
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several commercial and laboratory-developed methods have been described using techniques such as conventional polymerase chain reaction (PCR), multiplex PCR, real time PCR (RT-PCR), and gene-probe hybridization [
         <a href="#rid20">
          20
         </a>
         ]. These techniques allow detection of MRSA within two to six hours. However, the relatively high cost of molecular methods often necessitates batching of specimens, lengthening the turnaround time [
         <a href="#rid7">
          7
         </a>
         ]. Given the large number of SCC
         <em>
          mec
         </em>
         elements and variants, the performances of the different assays vary depending on the strains of MRSA and coagulase-negative staphylococci present in any given sample.
        </p>
        <p>
         First-generation molecular assays target the SCC
         <em>
          mec
         </em>
         -
         <em>
          orfX
         </em>
         junction. This target is present in some methicillin-resistant coagulase-negative staphylococci (MRCoNS), so false positives can occur in the presence of MRCoNS. When these assays are used on specimens such as nasal swabs where MRCoNS are frequently present, specificity can be compromised. In addition, these assays do not directly detect the
         <em>
          mecA
         </em>
         gene. This means that occasional isolates with SCC
         <em>
          mec
         </em>
         but without
         <em>
          mecA
         </em>
         ("
         <em>
          mecA
         </em>
         dropouts") can falsely identify as MRSA. Finally, these assays do not detect MRSA strains carrying the
         <em>
          mecC
         </em>
         gene. The sensitivity and specificity of these earlier assays compared to conventional culture for MRSA detection in surveillance swabs ranged from 90 to 98 percent and 91 to 99 percent, respectively [
         <a href="#rid21">
          21-24
         </a>
         ].
        </p>
        <p>
         Second-generation assays, approved by the US Food and Drug Administration from 2008, typically target three genes: SCC
         <em>
          mec
         </em>
         -
         <em>
          orfX
         </em>
         junction, the
         <em>
          mecA
         </em>
         gene, and the staphylococcal protein A (
         <em>
          spa
         </em>
         ) gene. The SCC
         <em>
          mec
         </em>
         -
         <em>
          orfX
         </em>
         identifies all staphylococci, the
         <em>
          mecA
         </em>
         gene identifies methicillin resistance, and the
         <em>
          spa
         </em>
         gene identifies
         <em>
          S. aureus
         </em>
         . All three targets must be positive for MRSA to be deemed present. These assays do not detect MRSA due to
         <em>
          mecC
         </em>
         . Third-generation assays contain the targets present in second-generation assays plus a
         <em>
          mecC
         </em>
         target.
        </p>
        <p>
         The reported performance of molecular assays is shown in the table  (
         <a class="graphic graphic_table graphicRef115026" href="/z/d/graphic/115026.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The EVIGENE MRSA kit detects
         <em>
          mecA
         </em>
         as well as two separate sequences specific for
         <em>
          S. aureus
         </em>
         using three specific DNA probes. It is available in parts of Europe but not in the United States [
         <a href="#rid25">
          25
         </a>
         ]. Unlike molecular assays that use PCR, this assay does not involve an amplification step. This assay showed sensitivity and specificity rates in excess of 99 percent for detection of MRSA in blood [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         A broad range of tests are under development; whole genome sequencing for MRSA detection may play an important role in the laboratory and at the point of care [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Laboratory developed
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several laboratory-developed assays using real-time PCR have been described. One widely studied method uses immune-mediated capture of
         <em>
          S. aureus
         </em>
         onto magnetic beads, followed by multiplex real-time PCR to detect
         <em>
          mecA
         </em>
         (within SCC
         <em>
          mec
         </em>
         ) and the
         <em>
          S. aureus
         </em>
         -specific
         <em>
          femA
         </em>
         gene [
         <a href="#rid27">
          27-29
         </a>
         ]. This assay was used in two studies evaluating the utility of molecular surveillance techniques for universal screening of surgical patients and as part of a strategy to reduce MRSA infections in intensive care units [
         <a href="#rid28">
          28,29
         </a>
         ]. Compared with conventional culture, the sensitivity and specificity of this technique was 100 percent [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Blood cultures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular assays can reduce the time to identification of MRSA in positive blood cultures with gram-positive cocci in clusters seen on Gram stain. Examples of performance characteristics of such assays are included in the table  (
         <a class="graphic graphic_table graphicRef115026" href="/z/d/graphic/115026.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The targets used in these assays tend to be the same as those used in assays intended for use on nasal swabs. Molecular assays that have not been validated for use on blood cultures may have unacceptable sensitivity due to potential PCR inhibitors present in blood culture media.
        </p>
        <p class="headingAnchor" id="H3875401024">
         <span class="h2">
          Respiratory cultures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rapid methods have also been applied to tracheal aspirate and bronchoalveolar lavage/wash specimens to help diagnose lower respiratory tract infection, including suspected ventilator-associated pneumonia [
         <a href="#rid31">
          31-34
         </a>
         ]. Performance characteristics of their application are included in the table. These off-label use reports have observed high negative predictive values for MRSA [
         <a href="#rid31">
          31-33
         </a>
         ] or, in the report of Paonessa et al, a low likelihood ratio for MRSA, indicating treatment for MRSA can be withheld. A study has evaluated a version of the GeneXpert assay designed for endotracheal aspirates [
         <a href="#rid35">
          35
         </a>
         ]. This assay performed well in detecting
         <em>
          S. aureus
         </em>
         but there were too few MRSA cases to allow analysis. In a setting with high rates of lower respiratory tract infections due to
         <em>
          S. aureus
         </em>
         , these assays would be useful in assisting in treatment decisions.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          CLINICAL APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selection of a rapid detection technique depends upon whether the assay is intended for active surveillance or rapid identification of MRSA from blood cultures or respiratory samples. If used for active surveillance, the choice of technique depends in part on MRSA prevalence in the population screened; it is prudent to avoid molecular assays with low specificity. If used for rapid identification of MRSA from blood cultures, an assay validated for this purpose should be selected. Selection of rapid detection technique also depends on the hospital's logistical needs and capacity to batch specimens, the technical expertise of laboratory staff, and financial resources.
        </p>
        <p>
         The clinical utility of direct MRSA detection in blood cultures should be carefully evaluated before routine testing is adopted. Rapid testing can result in a decreased time to optimization of antibiotic therapy [
         <a href="#rid36">
          36
         </a>
         ]. In a study, where 51 percent of blood isolates were MRSA, combining nucleic acid microarray testing with direct physician notification reduced the time to infectious disease consult and targeted treatment and was associated with lower in-hospital and 30-day mortality [
         <a href="#rid37">
          37
         </a>
         ]. The benefits and cost effectiveness of routine testing depend on the local prevalence of MRSA and local approaches to empiric treatment.
        </p>
        <p>
         In settings where empiric treatment commonly includes
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         , the likely value will be in reducing unnecessary use of this agent. Shorter durations of vancomycin or
         <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">
          linezolid
         </a>
         occurred when rapid detection was used for ventilated patients with suspected MRSA pneumonia [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1532694425">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110550.html" rel="external">
          "Society guideline links: Management of
          <i>
           Staphylococcus aureus
          </i>
          infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          Cefoxitin
         </a>
         disk diffusion testing is an accurate phenotypic method for determining whether a
         <em>
          Staphylococcus aureus
         </em>
         isolate is methicillin-resistant
         <em>
          S. aureus
         </em>
         (MRSA). A zone size &lt;22 mm indicates that the
         <em>
          mecA
         </em>
         gene is present, and the isolate should be reported as MRSA. (See
         <a class="local">
          'Cefoxitin disk screen test'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid culture methods that utilize chromogenic agar allow detection of MRSA from active surveillance specimens at 24 hours with high specificity but lower sensitivity than conventional culture. (See
         <a class="local">
          'Chromogenic agar'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For the purposes of MRSA infection control surveillance, the anterior nares are the most common site for MRSA carriage; other important sites include the throat, axilla, groin, and perineum. (See
         <a class="local">
          'Anatomic sampling site(s)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In general, molecular methods can detect MRSA with high sensitivity within several hours. Most techniques can reliably detect MRSA from active surveillance specimens. Several commercial assays have been developed for evaluation of positive blood cultures and show high sensitivity and specificity; only assays validated for this purpose should be used. (See
         <a class="local">
          'Laboratory tools'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The clinical utility of any testing algorithm for direct detection of MRSA in blood cultures needs to be carefully evaluated based on the local prevalence of MRSA, empiric treatment practices, and laboratory testing logistics. (See
         <a class="local">
          'Clinical approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some molecular methods may have poor specificity for MRSA when used on specimens containing mixtures of
         <em>
          S. aureus
         </em>
         and methicillin-resistant coagulase-negative staphylococci. These assays have limited utility in definitively identifying MRSA carriage in low-prevalence settings. (See
         <a class="local">
          'Molecular methods'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical issues related to MRSA surveillance are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3153.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA): Microbiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4048.html" rel="external">
          "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Reyes RC, Stoakes L, Milburn S, et al. Evaluation of a new chromogenic medium for the detection of methicillin-resistant Staphylococcus aureus carriage on nasal and perianal specimens. Diagn Microbiol Infect Dis 2008; 60:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bishop EJ, Grabsch EA, Ballard SA, et al. Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44:2904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rohrer S, Tschierske M, Zbinden R, Berger-Bächi B. Improved methods for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2001; 20:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desjardins M, Guibord C, Lalonde B, et al. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J Clin Microbiol 2006; 44:1219.
          </a>
         </li>
         <li class="breakAll">
          Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Clinical and Laboratory Standards Institute, Wayne, PA 2012.
         </li>
         <li class="breakAll">
          European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters
Version 11.0, valid from 2021-01-01
. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf (Accessed on January 03, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malhotra-Kumar S, Haccuria K, Michiels M, et al. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol 2008; 46:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pape J, Wadlin J, Nachamkin I. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol 2006; 44:2575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Compernolle V, Verschraegen G, Claeys G. Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007; 45:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Hal SJ, Stark D, Lockwood B, et al. Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 2007; 45:2486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cherkaoui A, Renzi G, François P, Schrenzel J. Comparison of four chromogenic media for culture-based screening of meticillin-resistant Staphylococcus aureus. J Med Microbiol 2007; 56:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perry JD, Davies A, Butterworth LA, et al. Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2004; 42:4519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahimana I, Francioli P, Blanc DS. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006; 12:1168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Louie L, Soares D, Meaney H, et al. Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44:4561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoakes L, Reyes R, Daniel J, et al. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ben Nsira S, Dupuis M, Leclercq R. Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2006; 27:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohara S, Malhotra-Kumar S, Haccuria K, et al. Novel rapid culture-based detection method for methicillin-resistant Staphylococcus [corrected] aureus. J Clin Microbiol 2008; 46:3181; author reply 381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-Álvarez L, Holden MT, Lindsay H, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011; 11:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shore AC, Deasy EC, Slickers P, et al. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:3765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll KC. Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status. Mol Diagn Ther 2008; 12:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holfelder M, Eigner U, Turnwald AM, et al. Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay. Clin Microbiol Infect 2006; 12:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paule SM, Hacek DM, Kufner B, et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 2007; 45:2993.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossney AS, Herra CM, Fitzgibbon MM, et al. Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens. Eur J Clin Microbiol Infect Dis 2007; 26:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolk DM, Picton E, Johnson D, et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009; 47:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levi K, Towner KJ. Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. J Clin Microbiol 2003; 41:3890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Belkum A, Rochas O. Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing. Front Microbiol 2018; 9:1437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francois P, Pittet D, Bento M, et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol 2003; 41:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10:R25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299:1149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francois P, Bento M, Renzi G, et al. Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007; 45:2011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cercenado E, Marín M, Burillo A, et al. Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol 2012; 50:4095.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leone M, Malavieille F, Papazian L, et al. Routine use of Staphylococcus aureus rapid diagnostic test in patients with suspected ventilator-associated pneumonia. Crit Care 2013; 17:R170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oh AC, Lee JK, Lee HN, et al. Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus. Mol Med Rep 2013; 7:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paonessa JR, Shah RD, Pickens CI, et al. Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial. Chest 2019; 155:999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coppens J, Van Heirstraeten L, Ruzin A, et al. Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples. Antimicrob Resist Infect Control 2019; 8:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang B, Jessamine P, Desjardins M, et al. Direct mecA polymerase chain reaction testing of blood culture bottles growing Gram-positive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia. Diagn Microbiol Infect Dis 2013; 75:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eby JC, Richey MM, Platts-Mills JA, et al. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia. Clin Infect Dis 2018; 66:64.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3166 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17959331" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Evaluation of a new chromogenic medium for the detection of methicillin-resistant Staphylococcus aureus carriage on nasal and perianal specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16891510" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11399018" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Improved methods for detection of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16597841" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16597841" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16597841" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18322065" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16825383" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17093032" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17537949" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17374891" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Comparison of four chromogenic media for culture-based screening of meticillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15472303" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17121622" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17050808" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16455933" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16690261" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18768661" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Novel rapid culture-based detection method for methicillin-resistant Staphylococcus [corrected] aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21641281" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21636525" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18288879" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17121621" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17626166" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17541656" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19129414" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12904411" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30008711" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12517857" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16469125" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18334690" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17428926" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22993185" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23919575" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Routine use of Staphylococcus aureus rapid diagnostic test in patients with suspected ventilator-associated pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23064681" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30776365" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30627428" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23102997" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Direct mecA polymerase chain reaction testing of blood culture bottles growing Gram-positive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29020181" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
